share_log

Lyell Immunopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals(Amendment)-Foresite Capital Fund IV, L.P. (“FCF IV”)(4.0%),Foresite Capital Management IV, LLC (“FCM IV”)(4.0%), etc.

Feb 13, 2023 17:02
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more